Monday June 26th 2017

Posts Tagged ‘liberation therapy’

Wolfville couple adamant Liberation treatment offers hope

Wolfville couple adamant Liberation treatment offers hope

Wolfville area resident Christopher Alkenbrack makes no bones about it. While scientists argue about the success of the so-called Liberation therapy for Multiple Sclerosis, Alkenbrack passionately promotes what worked for him. Alkenbrack is the president of the National [Read More]

CCSVI: Three Years Later

CCSVI: Three Years Later

It has been three years to the day since W5 first aired “The Liberation Procedure,” a ground-breaking investigation into a new condition called CCSVI. Italian vascular surgeon Dr. Paulo Zamboni proposed a novel theory that MS could be caused by blocked veins in the head [Read More]

Follow-up ultrasounds to be available for Sask. MS patients who seek treatment outside Canada

Follow-up ultrasounds to be available for Sask. MS patients who seek treatment outside Canada

Saskatchewan residents with multiple sclerosis who have travelled outside Canada for liberation therapy can soon be evaluated by sonographers using Doppler ultrasound at Radiology Associates of Regina (RAR). Dr. Kunal Goyal, a radiologist with the Regina Qu’Appelle [Read More]

 Page 1 of 14  1  2  3  4  5 » ...  Last » 

Latest Topics

Are static and functional balance abilities related in individuals with Multiple Sclerosis? – Pau M, Porta M, Coghe G, Corona F, Pilloni G, Lorefice…

Are static and functional balance abilities related in individuals with Multiple Sclerosis? – Pau M, Porta M, Coghe G, Corona F, Pilloni G, Lorefice…

BACKGROUND: In people with Multiple Sclerosis (pwMS), balance assessment is essential in estimating the risk of falls, [Read More]

CHMP Recommends Cladribine (Mavenclad) for Multiple Sclerosis CHMP Recommends Cladribine (Mavenclad) for Multiple Sclerosis

CHMP Recommends Cladribine (Mavenclad) for Multiple Sclerosis CHMP Recommends Cladribine (Mavenclad) for Multiple Sclerosis

The European Medicines Agency ’ s Committee for Medicinal Products for Human Use recommends approval of cladribine to [Read More]

Germany’s Merck gets EU backing for oral MS drug

Germany’s Merck gets EU backing for oral MS drug

FRANKFURT (Reuters) - Germany's Merck KGaA has won a key recommendation to become a late entrant to the market for oral [Read More]

New data at EAN show Roche ’s OCREVUS (ocrelizumab) significantly reduced multiple measures of disease progression in relapsing and primary…

New data at EAN show Roche ’s OCREVUS (ocrelizumab) significantly reduced multiple measures of disease progression in relapsing and primary…

Roche announced today that new post-hoc analyses from the OCREVUS ™ (ocrelizumab) Phase III clinical trial programme [Read More]

MS Society Hosts Joint Congressional Briefing on the Value of Rehabilitation

MS Society Hosts Joint Congressional Briefing on the Value of Rehabilitation

/About-the-Society/News/Society-Hosts-Joint-Congressional-Briefing-on-the [Read More]